Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Nicholas J. Silvestri, MD
Diagnostic Advances in gMG: Effective Tools and Techniques
Hans Katzberg, MD
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Jonathan Strober, MD
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Ocular to Generalized MG: How and Why the Disease Evolves
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
The Safety of Sodium Oxybate in Treating Narcolepsy
Clete A. Kushida, MD, PhD
Sally Ibrahim, MD, FAAP
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
Omer Abdul Hamid, MD
Nancy Kuntz, MD
Migvis Monduy, MD
Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
Nilika Singhal, MD
M. Scott Perry, MD
Elizabeth Anne Thiele, MD, PhD
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.